Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4DM3

Crystal structure of human PNMT in complex adohcy, resorcinol and imidazole

Summary for 4DM3
Entry DOI10.2210/pdb4dm3/pdb
DescriptorPhenylethanolamine N-methyltransferase, S-ADENOSYL-L-HOMOCYSTEINE, RESORCINOL, ... (5 entities in total)
Functional Keywordstransferase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight64819.15
Authors
Nair, P.C.,Malde, A.K.,Mark, A.E. (deposition date: 2012-02-06, release date: 2012-04-25, Last modification date: 2024-11-27)
Primary citationNair, P.C.,Malde, A.K.,Drinkwater, N.,Mark, A.E.
Missing fragments: detecting cooperative binding in fragment-based drug design.
ACS Med Chem Lett, 3:322-326, 2012
Cited by
PubMed Abstract: The aim of fragment-based drug design (FBDD) is to identify molecular fragments that bind to alternate subsites within a given binding pocket leading to cooperative binding when linked. In this study, the binding of fragments to human phenylethanolamine N-methyltransferase is used to illustrate how (a) current protocols may fail to detect fragments that bind cooperatively, (b) theoretical approaches can be used to validate potential hits, and (c) apparent false positives obtained when screening against cocktails of fragments may in fact indicate promising leads.
PubMed: 24900472
DOI: 10.1021/ml300015u
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4001 Å)
Structure validation

235183

PDB entries from 2025-04-23

PDB statisticsPDBj update infoContact PDBjnumon